GNRH1 and Dravet syndrome: Considering the unmet challenge of recruiting a longitudinal cohort of individuals with DS not receiving GnRH therapy, we took special care to provide optimal control for time-related effects by including typically developed healthy participants also scanned at two time points 6 months apart.